Addition of ixazomib to pomalidomide-dexamethasone improves progression-free survival for myeloma patients progressing on frontline lenalidomide: results of the randomized alliance study A061202 Meeting Abstract
| Authors: | Voorhees, P.; Suman, V.; Efebera, Y.; Raje, N.; Tuchman, S.; Rodriguez, C.; Santo, K.; Bova-Solem, M.; Carlisle, D.; Usmani, S.; McCarthy, P.; Richardson, P. |
| Abstract Title: | Addition of ixazomib to pomalidomide-dexamethasone improves progression-free survival for myeloma patients progressing on frontline lenalidomide: results of the randomized alliance study A061202 |
| Meeting Title: | 19th International Myeloma Society Annual Meeting (IMS) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. |
| Meeting Dates: | 2022 Aug 25-27 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-08-01 |
| Start Page: | S193 |
| Language: | English |
| ACCESSION: | WOS:000895909200338 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(22)00612-7 |
| Notes: | Meeting Abstract: P-282 -- Source: Wos |
